Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care



Rating:

Share or cite this content

Citations should be made in the following way:
I. Opitz (Zurich, Switzerland). Surgery in the era of immune and targeted therapy. Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care

Member's Comments

No comment yet.

Related content which might interest you: Combination therapy in the era of immunotherapy Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Optimisation of chemotherapy in the era of immunotherapy Source: Eur Respir J, 52 (4) 1801698; 10.1183/13993003.01698-2018 Year: 2018 Concomitant radiotherapy and targeted therapies Source: International Congress 2019 – New perspectives in thoracic surgical oncology Year: 2019 Achievements in targeted therapies Source: Eur Respir Monogr 2015; 68: 215-233 Year: 2015 Better diagnostics for targeted antibiotic therapy Source: Virtual Congress 2020 – Antibiotic resistance: the way forward Year: 2020 Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Optimizing the target therapy development Source: ERS Research Seminar Year: 2015 Adjuvant BCG immunotherapy induces an effective antiviral immune response in recurrent respiratory papillomatosis Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Screening for tuberculosis in candidates for immunosuppressive therapy Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 How to use new immunosuppressive drugs in lung transplantation Source: Annual Congress 2006 - MP5 – How to use new immunosuppressive drugs in lung transplantation Year: 2006 Tuberculosis screening in patients receiving biological therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Can the immune system be targeted to treat COVID-19? Source: Eur Respir Monogr 2021; 94: 69-85 Year: 2021 Surgery following neoadjuvant therapy is safe and offers improved long-term prognosis Source: Annual Congress 2007 - Controversies in surgical oncology Year: 2007 Unmasking tuberculosis in the era of antiretroviral treatment Source: Eur Respir J 2012; 39: 1064-1075 Year: 2012 Surgery as the best option in the multimodal treatment Source: Annual Congress 2013 –The management of N2 disease in non-small cell lung cancer Year: 2013 Role of pharmacogenomics in host response to treatment Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease Year: 2004